Skip to main content
. 2023 Mar 1;133(5):e164486. doi: 10.1172/JCI164486

Figure 1. Participant data flow.

Figure 1

For this study, young persons with type 2 diabetes treated with SGLT2 inhibitors or standard of care, from the IMPROVE-T2D and RENAL-HEIR observational studies, were included. Healthy controls from the CROCODILE study were included.